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1  | BACKGROUND
Public and patient involvement (PPI) in health research has been 
defined as research being carried out “with” or “by” members of 
the public rather than “to,” “about” or “for” them.1 PPI covers a 
diverse range of approaches from “one off” information gathering 
to sustained partnerships. Tritter’s conceptual framework for PPI 
distinguished between indirect involvement where information is 
gathered from patients and the public, but they do not have the 
power to make final decisions and direct involvement where pa-
tients and the public take part in the decision- making.2
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Background: The majority of studies included in recent reviews of impact for public 
and patient involvement (PPI) in health research had a qualitative design. PPI in solely 
quantitative designs is underexplored, particularly its impact on statistical analysis. 
Statisticians in practice have a long history of working in both consultative (indirect) 
and collaborative (direct) roles in health research, yet their perspective on PPI in 
quantitative health research has never been explicitly examined.
Objective: To explore the potential and challenges of PPI from a statistical perspec-
tive at distinct stages of quantitative research, that is sampling, measurement and 
statistical analysis, distinguishing between indirect and direct PPI.
Conclusions: Statistical analysis is underpinned by having a representative sample, 
and a collaborative or direct approach to PPI may help achieve that by supporting 
access to and increasing participation of under- represented groups in the population. 
Acknowledging and valuing the role of lay knowledge of the context in statistical 
analysis and in deciding what variables to measure may support collective learning 
and advance scientific understanding, as evidenced by the use of participatory mod-
elling in other disciplines. A recurring issue for quantitative researchers, which re-
flects quantitative sampling methods, is the selection and required number of PPI 
contributors, and this requires further methodological development. Direct ap-
proaches to PPI in quantitative health research may potentially increase its impact, 
but the facilitation and partnership skills required may require further training for all 
stakeholders, including statisticians.
K E Y W O R D S
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A bibliometric review of the literature reported strong growth 
in the number of published empirical health research studies with 
public involvement.3 In a systematic review of the impact of PPI on 
health and social care research, Brett et al4 reported positive im-
pacts at all stages of research from planning and undertaking the 
study to analysis, dissemination and implementation. The design of 
the majority of empirical research studies included in both reviews 
was qualitative (70% of studies in Brett. et al4 and 73% in Boote 
et al3). More significant tensions have been reported in community- 
academic partnerships that use quantitative methods rather than 
solely qualitative methods, for example tensions with the commu-
nity about having and recruiting to a “no intervention” comparison 
group.5 Particular challenges for PPI have been reported in the most 
structured and regulated of quantitative designs, that is a random-
ized controlled trial (RCT), where there is little opportunity for flex-
ibility once the trial has started6 and Boote et al3 concluded that 
researchers may find it easier to involve the public in qualitative 
rather than quantitative research.
If the full potential of PPI for health research is to be realized, 
its potential and challenges in quantitative research require more 
exploration, particularly the features of quantitative research which 
are different from qualitative research, for example, sampling, mea-
surement and statistical analysis. Statisticians in practice have a long 
history of working with a variety of stakeholders in health research 
and have examined the difference between an indirect or consulting 
role for the statistician and a more direct, collaborative role,7 yet 
their perspective has never been explicitly explored in health re-
search with PPI. The objective of this study therefore was to criti-
cally reflect on the potential and challenges for PPI at distinct stages 
of quantitative research from a statistical perspective, distinguishing 
between direct and indirect approaches to PPI.2
2  | SAMPLE SIZE AND SELEC TION
Quantitative research usually aims to provide precise, unbiased es-
timates of parameters of interest for the entire population which 
requires a large, randomly selected sample. Brett et al4 reported 
a positive impact of PPI on recruitment in studies, but the repre-
sentativeness of the sample is as important in quantitative research 
as sample size. Studies have shown that even when accrual targets 
have been met, the sample may not be fully representative of the 
population of interest. In cancer clinical trials, for example, those 
with health insurance and from higher socio- economic backgrounds 
can be over- represented, while older patients, ethnic minorities and 
so- called hard- to- reach groups (often with higher cancer mortality 
rates) are under- represented.8 This limits the ability to generalize the 
results of the trials to all those with cancer. There is evidence that 
a direct approach to PPI with sustained partnerships between com-
munity leaders, primary care providers and clinical trial researchers 
can be effective in increasing awareness and participation of under- 
represented groups in cancer clinical trials9,10 and therefore help to 
achieve the goal of a population- representative sample.
Collecting representative health data for some groups in 
the population may only be possible with their involvement. 
Marin et al11 reports on the challenges of identifying an appro-
priate sampling frame for a health survey of Aboriginal adults in 
Southern Australia. Access to information identifying Aboriginal 
dwellings was not publically available, making it difficult to ran-
domly select participants for large population household surveys. 
Trying to overcome this challenge involved reaching agreement 
on the process of research for Aboriginal adults with their local 
communities. An 8- month consultation process was undertaken 
with representatives from multiple locations including Aboriginal 
owned lands in one region; however, it was ultimately agreed that 
it was culturally inappropriate for the research team to survey 
this region. The study demonstrated the opportunities for PPI in 
quantitative research with a representative sample of randomly 
chosen Aboriginal adults (excluding those resident in one region) 
ultimately achieved but also the challenges for PPI. The direct ap-
proach to involvement in this study, after a lengthy consultation 
process, resulted in a decision not to carry out the planned sam-
pling and data collection in one region with implications for gener-
alization of results and overall sample size.
Of course, given the importance of representativeness in quan-
titative research, there may be particular challenges for statisticians 
and quantitative researchers in accepting the term patient or public 
representative with some suggesting PPI contributor as a more appro-
priate term.6 PPI representative may suggest to a quantitative re-
searcher that an individual patient or member of the public is typical 
of an often diverse population, yet there is evidence that the oppor-
tunities and capacity to be involved as PPI contributors vary by level 
of education, income, cognitive skills and cultural background.12 
Dudley et al carried out a qualitative study of the impact of PPI in 
RCTs with patients and researchers from a cohort of RCTs.6 The 
types of roles of PPI contributors described by researchers involved 
in the RCTs were grouped into oversight, managerial and responsive 
roles. Responsive PPI was described as informal and impromptu with 
researchers approaching multiple “responsive” PPI contributors as 
difficulties arose, for example advising on patient information sheets 
and follow- up of patients. It was reported that contributions from 
responsive roles may carry more weight with the researchers in 
RCTs because it allowed access to a more diverse range of contrib-
utors who researchers saw as more “representative” of the target 
population.
3  | ME A SUREMENT
Measurement of quantitative data involves decisions about what to 
measure, how to measure it and how often to measure it with these 
decisions typically made by the research team. Without the involve-
ment of patients and the public, however, important outcomes for 
people living with a condition have been missed or overlooked, for 
example fatigue for people with rheumatoid arthritis13 or the long- 
term effects of therapy for children with asthma.14
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Core outcome sets (COS) are a minimum set of agreed important 
outcomes to be measured in research on particular illnesses, condi-
tions or treatments to ensure important outcomes are consistently 
reported and allow the results from multiple studies to be easily com-
bined and compared. Young reported on workshops to explore what 
principles, methods and strategies that COS developers may need 
to consider when seeking patient input into the development of a 
COS.15 The importance of distinguishing between an indirect role for 
patients in COS development where patients respond to a consen-
sus survey or a direct role where patients are partners in planning, 
running and disseminating a COS study was highlighted by delegates 
in the workshops. While all delegates agreed that participation by 
patients should be meaningful and on an equal footing with other 
stakeholders, there was considerable uncertainty on how to achieve 
this, for example how many patients are needed in the COS develop-
ment process or what proportion of patients relative to other stake-
holders should be included. This raises the issue again of the number 
and selection of PPI contributors for quantitative researchers, and it 
was concluded that methodological work was needed to understand 
the COS development process from the perspective of patients and 
how the process may be improved for them.
Important considerations in longitudinal research are the num-
ber and timing of repeated measurements. From a statistical per-
spective, measurements on the same subject at different times are 
almost always correlated, with measurements taken close together 
in time being more highly correlated than measurements taken far 
apart in time. Unequal spacing of observation times may be more 
computationally challenging in statistical analysis of repeated mea-
surements and missing data within subjects over time can be partic-
ularly challenging depending on the amount, cause and pattern of 
missing data.16 There are therefore important statistical consider-
ations to be taken into account in the design of longitudinal studies 
but these have to be balanced with input from PPI contributors on 
appropriate timing and frequency of data collection for potential 
participants.
Lucas et al reported on how European birth cohorts are engaging 
and consulting with young birth cohort members.17 Of the 84 indi-
vidual cohorts identified, only eight had a mechanism for consult-
ing with parents and three a mechanism for consulting with young 
people themselves (usually “one off” consultations). Very varied fol-
low- up rates were reported from 13% to 84% more than 10 years 
after enrolment for individual data rounds of the birth cohorts.17 
Being motivated to continue to participate may be influenced by 
whether a participant believes the study is interesting, important, 
or relevant to them.18 One of the key strategies for retention in the 
Australian Aboriginal Birth Cohort study was partnerships with 
community members with local knowledge who were involved in 
all phases of the follow- up.19 Retention rates of 86% at 11- year fol-
low- up and 72% at 18- year follow- up were reported which demon-
strates the potential of a direct approach to PPI. Ethical approval for 
the study involved an Aboriginal Ethical Sub- committee which had 
the power of veto and a staged consent was used where participants 
had the right to refuse individual procedures at each wave. As with 
all missing data, this has implications for the statistical analysis yet 
only 10% of participants in this study chose to opt out of different 
assessments at follow- up.
3.1 | Statistical analysis
A report on the impact of PPI found that it had a positive impact at all 
stages of qualitative research including data analysis but that there 
was little evidence of its impact on quantitative data analysis.20 It 
was concluded this lack of evidence may reflect a lack of involve-
ment rather than an evidence gap. Booth et al3 also suggested that 
the public may be more comfortable with interpreting interview and 
focus group data compared with numeric data. Low levels of numeri-
cal and statistical literacy in the general population may contribute 
to this.
Statistical analysis involves describing the data using appropriate 
graphical and numerical summaries (descriptive statistics) and using 
more advanced statistical methods to draw inferences about the pop-
ulation using the data from a sample (statistical inference). Choosing 
appropriate methods for statistical inference, testing the underlying 
assumptions and checking the adequacy of the models produced re-
quires advanced statistical training and implementing them typically 
involves the use of statistical software or programming. Statisticians 
bring this expertise to quantitative health research and while it is im-
portant that the chosen methods are adequately communicated to 
all stakeholders, replicating this type of expertise in PPI contributors 
seems like an inefficient use of resources for PPI.
Quantitative data are, however, “not just numbers, they are 
numbers with a context”21 and most practising statisticians agree 
that knowledge of the context is needed to carry out even a purely 
technical role effectively.22 While many associate statistical analysis 
with objectivity, in practice, statisticians routinely use “subjective” 
external information to guide, for example the decision on what is 
a meaningful effect size; whether an outlier is an error in data entry 
or represents an unusual but meaningful observation; and potential 
issues with measurement of variables and confounding.23 Gelman 
and Hennin argue that we should move beyond the discussion of ob-
jectivity and subjectivity in statistics and “replace each of them with 
broader collections of attributes, with objectivity replaced by trans-
parency, consensus, impartiality and correspondence to observable 
reality, and subjectivity replaced by awareness of multiple perspec-
tives and context dependence.”23 This debate within statistics is rel-
evant for PPI where the perceived objectivity and standardization of 
statistical analysis can be used as a reason for lack of involvement.
External information and context are particularly important in 
statistical modelling where statisticians are often faced with many 
potential predictors of an outcome. The “best” way of selecting a 
multivariable model is still unresolved from a statistical perspective, 
and it is generally agreed that subject matter knowledge, when avail-
able, should guide model building.24 Even when the potential pre-
dictors are known, understanding the causal pathways of exposure 
on an outcome is challenging where the effect of a variable on the 
outcome can be direct or indirect. Christiaens et al25 used a causal 
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diagram to visualize the relationship between pain acceptance and 
personal control of women in labour and the use of pain medication 
during labour. Their analysis accounted for the maternal care context 
of the country where the women were giving birth and other charac-
teristics such as age of the woman and duration of labour. The choice 
of these characteristics was underpinned by a literature review but 
women who have given birth also have expert knowledge on why 
they use pain relief and how other variables such as their personal 
beliefs and social context might influence that decision.26
Collaborative or participatory modelling is an approach to scien-
tific modelling in areas such as natural resource management which 
involves all stakeholders in the model building process. Participants 
can suggest characteristics for inclusion in the model and how they 
may impact on the outcome. Causal diagrams are then used to create 
a shared view across stakeholders.27 Rockman et al28 concluded, in 
the context of marine policy, that “participatory modelling has the 
potential to facilitate and structure discussions between scientists 
and stakeholders about uncertainties and the quality of the knowl-
edge base. It can also contribute to collective learning, increase legit-
imacy and advance scientific understanding.”
There is emerging evidence that the importance of PPI in the 
development and application of modelling in health research is being 
recognized. Van Voorn29 discussed the benefits and risks of PPI in 
health economic modelling of cost- effectiveness of new drugs and 
treatment strategies, with public and patients described as the miss-
ing stakeholder group in the modelling process. The potential bene-
fits included the expertise that patients could bring to the process, 
a greater understanding and possible acceptance by patients of the 
results of the models and improved model validation. The risks in-
cluded potential patient bias and the increased resources required 
for training. The number and selection of patients to contribute to 
the process was also discussed with a suggestion to include patients 
“who were able to take a neutral view” and “at least five patients that 
differ significantly in their background,” again highlighting the focus 
of quantitative researchers on bias and sample size. The role for this 
type of participatory modelling in informing debate on public health 
problems is increasingly being recognized, drawing on the experi-
ence of its use in other areas where optimal use of limited resources 
is required to address complex problems in society.30
4  | CONCLUSIONS
Statistical analysis of quantitative data is underpinned by hav-
ing a representative sample, and there is evidence that a direct 
approach to PPI can help achieve that by supporting access to 
and increasing participation of under- represented groups in the 
population. The direct approach has also demonstrated its poten-
tial in the retention of those recruited over time, thus reducing 
bias caused by missing data in longitudinal studies. At all stages of 
statistical analysis, a statistician continuously refers back to the 
context of the data collected.22 Lay knowledge of PPI contribu-
tors has an important role in providing this context, and there is 
evidence from other disciplines of the benefits of including this 
knowledge in analysis to support collective learning and advance 
scientific understanding.
The direct approach to PPI where patients and the public have 
the power to make decisions also brings challenges and the statisti-
cian needs to be able to clearly communicate the impact of each de-
cision on the scientific rigour and validity of sampling, measurement 
and analysis to all stakeholders. Decisions made on participation 
impact on generalizability. Participatory modelling requires facilita-
tion and partnership skills which may require further training for all 
stakeholders, including statisticians.
The direct and indirect role for PPI contributors mirrors what 
happens for statisticians in practice. Statisticians can have a con-
sultative role, that is answering a specific statistical question 
or a collaborative role where a statistician works with others as 
equal partners to create new knowledge, with professional orga-
nizations for statisticians providing guidance and mentorship on 
moving from consulting to collaboration to leadership roles.7,31 
Statisticians therefore bring very relevant experience and un-
derstanding for PPI contributors on the ladder of participation in 
health research. Further exploration is required on the impact of 
direct compared to indirect involvement in quantitative research, 
drawing on the evidence base for community- based participatory 
research in quantitative designs9 and the framework for participa-
tory health research and epidemiology.32,33
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